B Cell Engineering and Tertiary Lymphoid Structure Induction via Biomaterials for Cancer Immunotherapy

Project Information

BeaT-IT

Grant agreement ID: 101040996

DOI

10.3030/101040996

EC signature date 11 February 2022

Start date 1 July 2022

End date 30 June 2027

Funded under

• European Research Council (ERC)

Total cost

€ 1 488 762,50

EU contribution

€ 1 488 762,50

Coordinated by

UNIVERSITAETSKLINIKUM AACHEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (4)

Advanced Materials

Author(s): Bai, Xiangyang; Sun, Qingxue; Cui, Hao; Guerzoni, Luis P. B.; Wuttke, Stefan; Kiessling, Fabian; De Laporte, Laura; Lammers, Twan; Shi, Yang
Published in: Advanced materials 34(39), 2109701 (2022). doi:10.1002/adma.202109701, 2022, ISSN 0935-9648
Publisher: United Nations Industrial Developement Organization
DOI: 10.18154/rwth-conv-250860

Biomaterials-mediated ligation of immune cell surface receptors for immunoengineering

Author(s): Hao Cui, Lili Zhang, Yang Shi
Published in: Immuno-Oncology and Technology, 2024, ISSN 2590-0188
Publisher: Elsevier Ltd.
DOI: 10.1016/j.iotech.2023.100695

Direct Immunoactivation by Chemotherapeutic Drugs in Cancer Treatment

Author(s): Yurui Wang; Yiran Song; Yazhi He; Yang Wang; Jochen Maurer; Fabian Kiessling; Twan Lammers; Feng Wang; Yang Shi
Published in: Adv. Therap. (2023). doi:10.1002/adtp.202300209, 2023, ISSN 2366-3987
Publisher: Wiley-VCH
DOI: 10.1002/adtp.202300209

Linking B cell metabolism to immune regulation: the neurotransmitter GABA

Author(s): Yang Shi
Published in: Signal transduction and targeted therapy 7, 260 (2022). doi:10.1038/s41392-022-01120-w, 2022, ISSN 2059-3635
Publisher: Nature Portfolio
DOI: 10.18154/rwth-2022-08067